Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

May 01, 2013; Volume 345,Issue 2

Highlighted Papers

  • You have access
    CB1 Receptor Signaling: A Key Interaction between Extracellular-3 Loop and Transmembrane Helix 2
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 169; DOI: https://doi.org/10.1124/jpet.112.0513HI
  • You have access
    Experimental Models of Disseminated Scedosporiosis with Cerebral Involvement
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 169; DOI: https://doi.org/10.1124/jpet.112.0513HIa
  • You have access
    Mechanism of LX4211 Induced Increases Serum GLP-1 and PYY Levels
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 169; DOI: https://doi.org/10.1124/jpet.112.0513HIb
  • You have access
    UGT 1A Polymorphism rs8330 Is Associated with Liver Acetaminophen Glucuronidation
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 169; DOI: https://doi.org/10.1124/jpet.112.0513HIc

Cardiovascular

  • You have access
    Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium
    Yu-Miao Wei, Xiang Li, Jing Xiong, Justine M. Abais, Min Xia, Krishna M. Boini, Yang Zhang and Pin-Lan Li
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 170-179; DOI: https://doi.org/10.1124/jpet.112.201442

Cellular and Molecular

  • You have access
    Chromatin Remodeling by Rosuvastatin Normalizes TSC2-/meth Cell Phenotype through the Expression of Tuberin
    Elena Lesma, Silvia Ancona, Emanuela Orpianesi, Vera Grande, Anna Maria Di Giulio and Alfredo Gorio
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 180-188; DOI: https://doi.org/10.1124/jpet.113.203141
  • You have access
    Novel Insights into CB1 Cannabinoid Receptor Signaling: A Key Interaction Identified between the Extracellular-3 Loop and Transmembrane Helix 2
    Jahan Marcu, Derek M. Shore, Ankur Kapur, Megan Trznadel, Alexandros Makriyannis, Patricia H. Reggio and Mary E. Abood
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 189-197; DOI: https://doi.org/10.1124/jpet.112.201046

Chemotherapy, Antibiotics, and Gene Therapy

  • You have access
    Experimental Models of Disseminated Scedosporiosis with Cerebral Involvement
    Bénédicte Lelièvre, Pierre Legras, Charlotte Godon, Florence Franconi, Jean-Paul Saint-André, Jean-Philippe Bouchara and Bertrand Diquet
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 198-205; DOI: https://doi.org/10.1124/jpet.112.201541

Drug Discovery and Translational Medicine

  • You have access
    Silibinin Synergizes with Histone Deacetylase and DNA Methyltransferase Inhibitors in Upregulating E-cadherin Expression Together with Inhibition of Migration and Invasion of Human Non-small Cell Lung Cancer Cells
    Samiha Mateen, Komal Raina, Chapla Agarwal, Daniel Chan and Rajesh Agarwal
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 206-214; DOI: https://doi.org/10.1124/jpet.113.203471
  • You have access
    Synergistic GABA-Enhancing Therapy against Seizures in a Mouse Model of Dravet Syndrome
    John C. Oakley, Alvin R. Cho, Christine S. Cheah, Todd Scheuer and William A. Catterall
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 215-224; DOI: https://doi.org/10.1124/jpet.113.203331
  • You have access
    Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
    Fen-Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura Kelley, Angelica Moksa, Shu-Yin Ho, Ekaterina Bykova, Min Wong, Palaniswami Rathanaswami, Sylvia Hu, John K. Sullivan, Hung Q. Nguyen and Helen J. McBride
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 225-238; DOI: https://doi.org/10.1124/jpet.112.202788

Endocrine and Diabetes

  • You have access
    The Heme Oxygenase System Selectively Enhances the Anti-Inflammatory Macrophage-M2 Phenotype, Reduces Pericardial Adiposity, and Ameliorated Cardiac Injury in Diabetic Cardiomyopathy in Zucker Diabetic Fatty Rats
    Ashok Jadhav, Shuchita Tiwari, Paul Lee and Joseph Fomusi Ndisang
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 239-249; DOI: https://doi.org/10.1124/jpet.112.200808
  • You have access
    LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose
    David R. Powell, Melinda Smith, Jennifer Greer, Angela Harris, Sharon Zhao, Christopher DaCosta, Faika Mseeh, Melanie K. Shadoan, Arthur Sands, Brian Zambrowicz and Zhi-Ming Ding
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 250-259; DOI: https://doi.org/10.1124/jpet.113.203364

Gastrointestinal, Hepatic, Pulmonary, and Renal

  • You have access
    Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
    Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051
  • You have access
    Long-Acting Human Serum Albumin-Thioredoxin Fusion Protein Suppresses Bleomycin-Induced Pulmonary Fibrosis Progression
    Ryota Tanaka, Hiroshi Watanabe, Azusa Kodama, Victor Tuan Giam Chuang, Yu Ishima, Keisuke Hamasaki, Ken-ichiro Tanaka, Tohru Mizushima, Masaki Otagiri and Toru Maruyama
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 271-283; DOI: https://doi.org/10.1124/jpet.112.201814

Inflammation, Immunopharmacology, and Asthma

  • You have access
    A Novel Nontoxic Inhibitor of the Activation of NADPH Oxidase Reduces Reactive Oxygen Species Production in Mouse Lung
    Intae Lee, Chandra Dodia, Shampa Chatterjee, John Zagorski, Clementina Mesaros, Ian A. Blair, Sheldon I. Feinstein, Mahendra Jain and Aron B. Fisher
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 284-296; DOI: https://doi.org/10.1124/jpet.112.201079

Metabolism, Transport, and Pharmacogenomics

  • You have access
    The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C>G (rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a/5b Splice Variant mRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure
    Michael H. Court, Marina Freytsis, Xueding Wang, Inga Peter, Chantal Guillemette, Suwagmani Hazarika, Su X. Duan, David J. Greenblatt, William M. Lee and the Acute Liver Failure Study Group
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 297-307; DOI: https://doi.org/10.1124/jpet.112.202010
  • You have access
    Metabolism of Beclomethasone Dipropionate by Cytochrome P450 3A Enzymes
    Jessica K. Roberts, Chad D. Moore, Robert M. Ward, Garold S. Yost and Christopher A. Reilly
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 308-316; DOI: https://doi.org/10.1124/jpet.112.202556

Neuropharmacology

  • You have access
    Ethanol Activation of Protein Kinase A Regulates GABAA α1 Receptor Function and Trafficking in Cultured Cerebral Cortical Neurons
    Stephen L. Carlson, Sandeep Kumar, David F. Werner, Christopher E. Comerford and A. Leslie Morrow
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 317-325; DOI: https://doi.org/10.1124/jpet.112.201954

Errata

  • You have access
    Correction to “R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation”
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 326; DOI: https://doi.org/10.1124/jpet.112.05er13
  • You have access
    Correction to “Using Chimeric Mice with Humanized Livers to Predict Human Drug Metabolism and a Drug-Drug Interaction”
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 327; DOI: https://doi.org/10.1124/jpet.112.05er13a
  • You have access
    Correction to “ADX71743, a Potent and Selective Negative Allosteric Modulator of Metabotropic Glutamate Receptor 7: In Vitro and In Vivo Characterization”
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 328; DOI: https://doi.org/10.1124/jpet.112.05er13b
  • You have access
    Correction to “Mending Leaky Blood Vessels: The Angiopoietin-Tie2 Pathway in Sepsis”
    Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 329; DOI: https://doi.org/10.1124/jpet.112.05er13c
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 345 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 345, Issue 2
1 May 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Highlighted Papers
  • Cardiovascular
  • Cellular and Molecular
  • Chemotherapy, Antibiotics, and Gene Therapy
  • Drug Discovery and Translational Medicine
  • Endocrine and Diabetes
  • Gastrointestinal, Hepatic, Pulmonary, and Renal
  • Inflammation, Immunopharmacology, and Asthma
  • Metabolism, Transport, and Pharmacogenomics
  • Neuropharmacology
  • Errata
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics